Screener
Ionis Pharmaceuticals IONS Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
| Line item | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|
| Proceeds from issuance of common stock through equity plans, net | 77,560 | 3,528 |
| Repayment of 0 percent convertible senior notes due 2026 | (432,511) | - |
| Principal payments on mortgage debt | (85) | (82) |
| Net cash provided by (used in) financing activities | (355,036) | 3,446 |
| Effects of exchange rates on cash | (188) | 827 |
| Net increase (decrease) in cash and cash equivalents | (22,195) | 55,227 |
| Cash and cash equivalents at beginning of period | 372,260 | 242,077 |
| Cash and cash equivalents at end of period | $$350,065 | 297,304 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ionis Pharmaceuticals's financing cash flow?
- Ionis Pharmaceuticals (IONS) reported financing cash flow of -$412.29M in Q2 2026.
- How has Ionis Pharmaceuticals's financing cash flow changed year-over-year?
- Ionis Pharmaceuticals's financing cash flow decreased by 33162.9% year-over-year, from $1.25M to -$412.29M.
- What is the long-term trend for Ionis Pharmaceuticals's financing cash flow?
- Over 2 years (2023 to 2025), Ionis Pharmaceuticals's financing cash flow has grown at a -0.0% compound annual growth rate (CAGR), from $676.35M to $675.84M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about Ionis Pharmaceuticals's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude